Literature DB >> 25667407

Up-regulation of silent information regulator 2 (Sir2) is associated with amphotericin B resistance in clinical isolates of Leishmania donovani.

Bidyut Purkait1, Ruby Singh1, Kirti Wasnik2, Sushmita Das3, Ashish Kumar1, Mark Paine4, Manas Dikhit1, Dharmendra Singh1, Abul H Sardar1, Ayan K Ghosh1, Pradeep Das5.   

Abstract

OBJECTIVE: Silent information regulator 2 (Sir2) is involved in parasite survival and apoptosis. Here, we aimed to explore the involvement of Sir2 in amphotericin B (AmB) resistance mechanism in Leishmania donovani.
METHODS: The expression levels of Sir2, MDR1 and NAD(+) biosynthetic pathway enzymes in AmB-resistant and -susceptible parasites were measured and total intracellular NAD(+)/NADH ratios were compared. Overexpression and knockout constructs of Sir2 were transfected in AmB-resistant and -susceptible parasites. Both resistant and susceptible parasites were inhibited with sirtinol for 4 h. The deacetylase activity of Sir2, the expression level of MDR1, the rate of AmB efflux, concentrations of reactive oxygen species (ROS) and levels of apoptosis were examined in WT, inhibited and transfected parasites, and the AmB susceptibility of the respective parasites was measured by determining the LD50 of AmB.
RESULTS: Levels of mRNA, protein and NAD(+)-dependent deacetylase activity of Sir2 were elevated in resistant versus susceptible parasites. Inhibition and/or deletion of Sir2 allele showed a decreased mRNA level of MDR1, lower drug efflux, increased ROS concentration, apoptosis-like phenomenon and decreased LD50 of AmB in resistant parasites. In contrast, Sir2 overexpression in susceptible parasites reversed drug susceptibility producing a resistant phenotype. This was associated with increased LD50 of AmB along with increased expression levels of MDR1, drug efflux and reduced concentrations of ROS, corresponding to decreased apoptosis of resistant to WT sensitive.
CONCLUSIONS: Sir2 plays a critical role in AmB resistance by regulating MDR1, ROS concentration and apoptosis-like phenomena and may be a new resistance marker for visceral leishmaniasis.
© The Author 2015. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  AmB resistance; MDR1; ROS; Sir2; apoptosis; visceral leishmaniasis

Mesh:

Substances:

Year:  2015        PMID: 25667407     DOI: 10.1093/jac/dku534

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  10 in total

1.  In Vitro Evaluation of Antileishmanial Activity of Computationally Screened Compounds against Ascorbate Peroxidase To Combat Amphotericin B Drug Resistance.

Authors:  Rani Mansuri; Ashish Kumar; Sindhuprava Rana; Bhavana Panthi; M Yousuf Ansari; Sushmita Das; Manas Ranjan Dikhit; Ganesh Chandra Sahoo; Pradeep Das
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

2.  Amphotericin B resistance in Leishmania mexicana: Alterations to sterol metabolism and oxidative stress response.

Authors:  Edubiel A Alpizar-Sosa; Nur Raihana Binti Ithnin; Wenbin Wei; Andrew W Pountain; Stefan K Weidt; Anne M Donachie; Ryan Ritchie; Emily A Dickie; Richard J S Burchmore; Paul W Denny; Michael P Barrett
Journal:  PLoS Negl Trop Dis       Date:  2022-09-28

3.  Activity of a novel sulfonamide compound 2-nitro-N-(pyridin-2-ylmethyl)benzenesulfonamide against Leishmania donovani.

Authors:  Manas R Dikhit; Bidyut Purkait; Ruby Singh; Bikash Ranjan Sahoo; Ashish Kumar; Rajiv K Kar; Md Yousuf Ansari; Savita Saini; Kumar Abhishek; Ganesh C Sahoo; Sushmita Das; Pradeep Das
Journal:  Drug Des Devel Ther       Date:  2016-05-26       Impact factor: 4.162

4.  In vitro evaluation of antimicrobial agents on Acanthamoeba sp. and evidence of a natural resilience to amphotericin B.

Authors:  Alexandre Taravaud; Philippe M Loiseau; Sébastien Pomel
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2017-09-08       Impact factor: 4.077

5.  Genomic and transcriptomic alterations in Leishmania donovani lines experimentally resistant to antileishmanial drugs.

Authors:  Alberto Rastrojo; Raquel García-Hernández; Paola Vargas; Esther Camacho; Laura Corvo; Hideo Imamura; Jean-Claude Dujardin; Santiago Castanys; Begoña Aguado; Francisco Gamarro; Jose M Requena
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2018-04-13       Impact factor: 4.077

6.  Chemotherapeutic efficacies of a clofazimine and diminazene aceturate combination against piroplasm parasites and their AT-rich DNA-binding activity on Babesia bovis.

Authors:  Bumduuren Tuvshintulga; Mahmoud AbouLaila; Thillaiampalam Sivakumar; Dickson Stuart Tayebwa; Sambuu Gantuya; Khandsuren Naranbaatar; Aki Ishiyama; Masato Iwatsuki; Kazuhiko Otoguro; Satoshi Ōmura; Mohamad Alaa Terkawi; Azirwan Guswanto; Mohamed Abdo Rizk; Naoaki Yokoyama; Ikuo Igarashi
Journal:  Sci Rep       Date:  2017-10-24       Impact factor: 4.379

Review 7.  Leishmania-Host Interactions-An Epigenetic Paradigm.

Authors:  Farhat Afrin; Inbesat Khan; Hassan A Hemeg
Journal:  Front Immunol       Date:  2019-03-22       Impact factor: 7.561

8.  Effect of Blastocystis sp. in dengue patients-Increase in the treatment cost and exacerbation of symptoms.

Authors:  Gaythri Thergarajan; Suresh Kumar; Subha Bhassu; Sharifah Faridah Binti Syed Omar; Sanjay Rampal
Journal:  PLoS One       Date:  2019-03-20       Impact factor: 3.240

9.  Editorial: Signaling in stress sensing and resistance in parasitic protozoa.

Authors:  Arijit Bhattacharya; Christopher Fernandez-Prada; Guillermo Daniel Alonso; Arunima Biswas
Journal:  Front Cell Infect Microbiol       Date:  2022-07-29       Impact factor: 6.073

10.  Universal minicircle sequence binding protein of Leishmania donovani regulates pathogenicity by controlling expression of cytochrome-b.

Authors:  Ruby Singh; Bidyut Purkait; Kumar Abhishek; Savita Saini; Sushmita Das; Sudha Verma; Abhishek Mandal; Ayan Kr Ghosh; Yousuf Ansari; Ashish Kumar; Abul H Sardar; Ajay Kumar; Pradeep Parrack; Pradeep Das
Journal:  Cell Biosci       Date:  2016-02-17       Impact factor: 9.584

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.